Premium
Ablation of Severe Drug‐Resistant Tachyarrhythmia During Pregnancy
Author(s) -
SZUMOWSKI LUKASZ,
SZUFLADOWICZ EWA,
ORCZYKOWSKI MICHAŁ,
BODALSKI ROBERT,
DEREJKO PAWEŁ,
PRZYBYLSKI ANDRZEJ,
URBANEK PIOTR,
KUŚMIERCZYK MARIUSZ,
KOŹLUK EDWARD,
SACHER FREDERIC,
SANDERS PRASHANTHAN,
DANGEL JOANNA,
HAISSAGUERRE MICHEL,
WALCZAK FRANCISZEK
Publication year - 2010
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/j.1540-8167.2010.01727.x
Subject(s) - medicine , ablation , pregnancy , tachycardia , cardiology , atrial fibrillation , catheter ablation , radiofrequency ablation , ejection fraction , anesthesia , heart failure , genetics , biology
Ablation of Tachyarrhythmia During Pregnancy. Aims: The goal of this study was to describe mapping and ablation of severe arrhythmias during pregnancy, with minimum or no X‐ray exposure. Treatment of tachyarrhythmia in pregnancy is a clinical problem. Pharmacotherapy entails a risk of adverse effects and is unsuccessful in some patients. Radiofrequency ablation has been performed rarely, because of fetal X‐ray exposure and potential maternal and fetus complications.Group and Method:Mapping and ablation was performed in 9 women (age 24–34 years) at 12–38th week of pregnancy. Three had permanent junctional reciprocating tachycardia, and 2 had incessant atrial tachycardia. Four of them had left ventricular ejection fraction ≤45%. One patient had atrioventricular nodal reciprocating tachycardia requiring cardioversion. Three patients had Wolff‐Parkinson‐White syndrome. Two of them had atrial fibrillation with ventricular rate 300 bpm and 1 had atrioventricular tachycardia 300 bpm. Fetal echocardiography was performed before and after the procedure.Results:Three women had an electroanatomic map and ablation done without X‐ray exposure. The mean fluoroscopy time in the whole group was 42 ± 37 seconds. The mean procedure time was 56 ± 18 minutes. After the procedure, all women and fetuses were in good condition. After a mean period of 43 ± 23 months follow up (FU), all patients were free of arrhythmia without complications related to ablation either in the mothers or children.Conclusion:Ablation can be performed safely with no or minimal radiation exposure during pregnancy. In the setting of malignant, drug‐resistant arrhythmia, ablation may be considered a therapeutic option in selected cases. (J Cardiovasc Electrophysiol, Vol. 21, pp. 877‐882, August 2010)